Literature DB >> 307029

T cell growth factor: parameters of production and a quantitative microassay for activity.

S Gillis, M M Ferm, W Ou, K A Smith.   

Abstract

Several soluble factors have recently been associated with the proliferation and differentiation of thymus-derived lymphocytes. One of these factors present in medium conditioned by T cell mitogen-stimulated lymphocytes has the ability to promote the long-term culture of normal and antigen-specific cytotoxic T cells. We report a method to test for this proliferative stimulus in the form of a sensitive microassay based upon the tritiated-thymidine incorporation of continuous murine tumor-specific cytotoxic T cell lines (CTLL). The microassay requires microliter quantitites of sample fluid and is amenable to quantitative analysis. This highly reproducible, quantitative assay for T cell growth factor (TCGF) has allowed investigation as to the kinetics of TCGF generation and has revealed that T lymphocytes are required for its production. Further investigation has supported the notion that this nonspecies-specific factor is actively removed from tissue culture medium by the proliferation of either T cell mitogen-activated lymphocytes or CTLL.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307029

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  834 in total

Review 1.  Cryopreserved normal macrophages as a control for assays of macrophage function.

Authors:  L S Lamb; J B Willoughby; W F Willoughby
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-02       Impact factor: 2.416

2.  Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.

Authors:  K Eriksson; I Nordström; C Czerkinsky; J Holmgren
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Differing processing requirements of four recombinant antigens containing a single defined T-cell epitope for presentation by major histocompatibility complex class II.

Authors:  L Colledge; M Y Sun ; W Lin; C C Blackburn; P A Reay
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

4.  A novel hepatic-targeting system for therapeutic cytokines that delivers to the hepatic asialoglycoprotein receptor, but avoids receptor-mediated endocytosis.

Authors:  Haruya Sato; Yukio Kato; Eiko Hayasi; Tomoyuki Tabata; Manabu Suzuki; Yoshiyuki Takahara; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

5.  Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1.

Authors:  Jiraprapa Wipasa; Huji Xu; Morris Makobongo; Michelle Gatton; Anthony Stowers; Michael F Good
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 6.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

7.  Proliferation in vitro of Lyt2-,L3T4- thymocytes shows responsiveness to interleukin 1.

Authors:  G Chaudhri; I A Clark; R Ceredig
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

8.  Interleukin 2 inhibitor in synovial fluid.

Authors:  P Emery; K C Gentry; A Kelso; I R Mackay
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

9.  Interleukin-2 production in Brown-Norway rats with HgCl2-induced autoimmune disease: paradoxical in vivo versus in vitro findings.

Authors:  D Baran; O Lantz; P Dosquet; A Sfaksi; P Druet
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

10.  Limiting-dilution analysis of T cells extracted from solid human lung tissue: comparison of precursor frequencies for proliferative responses and lymphokine production between lung and blood T cells from individual donors.

Authors:  P G Holt; U R Kees; M A Shon-Hegrad; A Rose; J Ford; N Bilyk; R Bowman; B W Robinson
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.